Allarity Therapeutics Inc (ALLR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALLR | AZN | AMGN | GILD | BMY |
| Company | Allarity Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 1.2700 | 202.48 | 352.09 | 137.99 | 58.11 |
| High | 1.2899 | 203.18 | 352.62 | 139.55 | 58.90 |
| Low | 1.1800 | 200.70 | 345.49 | 137.02 | 57.55 |
| Latest | 1.1900 | 202.24 | 349.82 | 139.03 | 58.06 |
| Change | -0.0800 | -1.79 | -1.20 | +0.04 | -0.56 |
| % Change | -6.30% | -0.88% | -0.34% | +0.03% | -0.96% |
| Volume | 219,400 | 1,723,687 | 2,544,550 | 4,791,426 | 9,844,173 |
| 20-Day Average Volume | 119,894 | 1,864,623 | 2,737,002 | 5,817,021 | 13,178,111 |
| Previous Close | 1.2700 | 204.03 | 351.02 | 138.99 | 58.62 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.1470 | 194.38 | 350.98 | 139.51 | 58.98 |
| 20-Day Raw Stochastic | 59.34% | 80.01% | 35.54% | 38.77% | 24.42% |
| 20-Day Relative Strength | 54.75 | 57.07 | 45.28 | 46.82 | 46.48 |
| Weighted Alpha | -22.59 | +48.53 | +24.16 | +31.75 | +21.65 |
| Today's Opinion | 8% Buy | 88% Buy | 24% Buy | 40% Buy | 48% Buy |
| Previous Opinion | 24% Buy | 88% Buy | 40% Buy | 40% Buy | 48% Buy |
| Last Month's Opinion | 8% Sell | 56% Buy | 88% Buy | 88% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.69% since 04/06/26 | -0.25% since 04/06/26 | +1.53% since 04/06/26 | -0.91% since 04/06/26 | -2.48% since 04/06/26 |
| Low | 1.1301 on 04/10/26 | 196.95 on 04/07/26 | 335.06 on 04/07/26 | 137.02 on 04/13/26 | 57.55 on 04/13/26 |
| High | 1.2900 on 04/13/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 59.80 on 04/10/26 |
| 1-Month | |||||
| %Chg | -4.76% since 03/13/26 | +6.54% since 03/13/26 | -5.03% since 03/13/26 | -4.23% since 03/13/26 | -2.06% since 03/13/26 |
| Low | 1.0100 on 03/31/26 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 1.3302 on 03/17/26 | 207.30 on 04/10/26 | 370.89 on 03/16/26 | 146.71 on 03/17/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | -0.83% since 01/13/26 | +7.04% since 01/13/26 | +7.24% since 01/13/26 | +14.04% since 01/13/26 | +3.47% since 01/13/26 |
| Low | 0.7687 on 02/03/26 | 178.08 on 01/21/26 | 321.71 on 01/20/26 | 120.94 on 01/15/26 | 53.54 on 01/21/26 |
| High | 1.4150 on 03/09/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -21.57% since 10/13/25 | +19.70% since 10/13/25 | +18.94% since 10/13/25 | +17.47% since 10/13/25 | +32.89% since 10/13/25 |
| Low | 0.7687 on 02/03/26 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 1.5600 on 10/14/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 20,090 | 316,431,744 | 189,440,224 | 172,517,456 | 119,686,496 |
| Shares Outstanding, K | 15,819 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 320,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -11,230,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 320,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -3,370,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.01 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.21 on 03/30/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/08/26 | 05/05/26 | 04/30/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.38 | 16.27 | 17.43 | 9.67 |